In silico identification of novel 5-HT_2A antagonists supported with ligand- and target-based drug design methodologies

References

• ADMET Predictor v 9.5, n.d. Simulations plus inc., lancaster, CA, USA
   Google Scholar
• Almaula, N., Ebersole, B. J., Zhang, D., Weinstein, H., & Sealfon, S. C. (1996). Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine 2A Receptor: Ser 3.36(159) PROVIDES A Second Interaction Site For The Protonated Amine Of Serotonin But Not Of Lysergic Acid Diethylamide Or Bufotenin. Journal of Biological Chemistry, 271(25), 14672–14675. doi:10.1074/jbc.271.25.14672
   PubMed Web of Science ®Google Scholar
• Baroni, M., Costantino, G., Cruciani, G., Riganelli, D., Valigi, R., & Clementi, S. (1993). Generating optimal linear PLS estimations (GOLPE): An advanced chemometric tool for handling 3D-QSAR problems. Quantitative Structure-Activity Relationships, 12(1), 9–20. doi:10.1002/qsar.19930120103
   Google Scholar
• Celada, P., Bortolozzi, A., & Artigas, F. (2013). Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: Rationale and current status of research. CNS Drugs, 27(9), 703–716. doi:10.1007/s40263-013-0071-0
   PubMed Web of Science ®Google Scholar
• Chem3D Ultra v 7.0, (2001). Cambridge Soft Corporation, 100 Cambridge Park Dr, Cambridge, USA.
   Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Darmon, M., Al Awabdh, S., Emerit, M.-B., & Masson, J. (2015). Chapter Five - Insights into serotonin receptor trafficking: Cell membrane targeting and internalization. In: Wu, G. (Ed.), Progress in molecular biology and translational science, trafficking of GPCRs. Oxford, UK: Academic Press. pp. 97–126. doi:10.1016/bs.pmbts.2015.02.009
   Google Scholar
• Davies, M., Nowotka, M., Papadatos, G., Dedman, N., Gaulton, A., Atkinson, F., Bellis, L., & Overington, J. P. (2015). ChEMBL web services: Streamlining access to drug discovery data and utilities. Nucleic Acids Research, 43(W1), W612–W620. doi:10.1093/nar/gkv352
   PubMed Web of Science ®Google Scholar
• Davis, R., & Wilde, M. I. (1996). Mirtazapine. CNS drugs, 5, 389–402. doi:10.2165/00023210-199605050-00007
   Google Scholar
• Denys, D., Van Nieuwerburgh, F., Deforce, D., & Westenberg, H. G. M. (2006). Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. Journal of Affective Disorders, 91(1), 39–44. doi:10.1016/j.jad.2005.12.011
   PubMed Web of Science ®Google Scholar
• Désaméricq, G., Schurhoff, F., Meary, A., Szöke, A., Macquin-Mavier, I., Bachoud-Lévi, A. C., & Maison, P. (2014). Long-term neurocognitive effects of antipsychotics in schizophrenia: A network meta-analysis. European Journal of Clinical Pharmacology, 70(2), 127–134. doi:10.1007/s00228-013-1600-y
   PubMed Web of Science ®Google Scholar
• Durán, Á., Martínez, G. C., & Pastor, M. (2008). Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in molecular interaction fields. Journal of Chemical Information and Modeling, 48(9), 1813–1823. doi:10.1021/ci800037t
   PubMed Web of Science ®Google Scholar
• Duran, A., & Pastor, M. (2011). An advanced tool for computing and handling grid-independent. Descriptors. User Manual Version 1.06.
   Google Scholar
• Durán, Á., Zamora, I., & Pastor, M. (2009). Suitability of GRIND-based principal properties for the description of molecular similarity and ligand-based virtual screening. Journal of Chemical Information and Modeling, 49(9), 2129–2138. doi:10.1021/ci900228x
   PubMed Web of Science ®Google Scholar
• Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11(5), 905–919. doi:10.1038/nprot.2016.051
   PubMed Web of Science ®Google Scholar
• Frazer, A., & Hensler, J. G. (1999). Serotonin involvement in physiological function and behavior. In Siegel G. J., Agranoff B. W., Albers R. W., et al., (Eds.), Basic neurochem. mol. cell. med. asp. (6th ed., Chapter 13, pp. 263–292). Philadelphia: Lippincott-Raven.
   Google Scholar
• Frisch, M. J. (1998). Gaussian 98 (RevisionA.7). Pittsburgh, PA: Gaussian, Inc.
   Google Scholar
• Ghosh, J., Lawless, M. S., Waldman, M., Gombar, V., & Fraczkiewicz, R. (2016). Modeling ADMET. Methods in Molecular Biology (Clifton, N.J.), 1425, 63–83. doi:10.1007/978-1-4939-3609-0_4
   PubMedGoogle Scholar
• Gianotti, M., Corti, C., Delle Fratte, S., Di Fabio, R., Leslie, C. P., Pavone, F., Piccoli, L., Stasi, L., & Wigglesworth, M. J. (2010). Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders. Bioorganic and Medicinal Chemistry Letters., 20(17), 5069–5073. doi:10.1016/j.bmcl.2010.07.029
   PubMed Web of Science ®Google Scholar
• Golbraikh, A., & Tropsha, A. (2002). Beware of q2!. Journal of Molecular Graphics and Modelling, 20(4), 269–276. doi:10.1016/S1093-3263(01)00123-1
   PubMed Web of Science ®Google Scholar
• Graham, J. M., Coughenour, L. L., Barr, B. M., Rock, D. L., & Nikam, S. S. (2008). 1-Aminoindanes as novel motif with potential atypical antipsychotic properties. Bioorganic and Medicinal Chemistry Letters., 18(2), 489–493. doi:10.1016/j.bmcl.2007.11.106
   PubMed Web of Science ®Google Scholar
• Gramatica, P. (2007). Principles of QSAR models validation: Internal and external. QSAR & Combinatorial Science, 26(5), 694–701. doi:10.1002/qsar.200610151
   Google Scholar
• Holmes, I. P., Micheli, F., Gaines, S., Lorthioir, O., Watson, S. P., Fabio, R. D., Gentile, G., Heidbreder, C., Savoia, C., & Worby, A. (2009). Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part one: Lead identification. Bioorganic and Medicinal Chemistry Letters., 19(16), 4799–4801. doi:10.1016/j.bmcl.2009.06.043
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. 27–28. doi:10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jensen, A. A., Plath, N., Pedersen, M. H. F., Isberg, V., Krall, J., Wellendorph, P., Stensbøl, T. B., Gloriam, D. E., Krogsgaard-Larsen, P., & Frølund, B. (2013). Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: Novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties. Journal of Medicinal Chemistry, 56(3), 1211–1227. doi:10.1021/jm301656h
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology., 267(3), 727–748. doi:10.1006/jmbi.1996.0897
   PubMed Web of Science ®Google Scholar
• Kanagarajadurai, K., Malini, M., Bhattacharya, A., Panicker, M. M., & Sowdhamini, R. (2009). Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding. Molecular Biosystems, 5(12), 1877–1888. doi:10.1039/b906391a
   PubMed Web of Science ®Google Scholar
• Kimura, K. T., Asada, H., Inoue, A., Kadji, F. M. N., Im, D., Mori, C., Arakawa, T., Hirata, K., Nomura, Y., Nomura, N., Aoki, J., Iwata, S., & Shimamura, T. (2019). Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine. Nature Structural & Molecular Biology, 26(2), 121–128. doi:10.1038/s41594-018-0180-z
   PubMed Web of Science ®Google Scholar
• Korb, O., StüTzle, T., & Exner, T. E. (2009). Empirical scoring functions for advanced protein-ligand docking with PLANTS. Journal of Chemical Information and Modeling, 49(1), 84–96. doi:10.1021/ci800298z
   PubMed Web of Science ®Google Scholar
• Koskinen, T., Ruotsalainen, S., Puumala, T., Lappalainen, R., Koivisto, E., Männistö, P. T., & Sirviö, J. (2000). Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology, 39(3), 471–481. doi:10.1016/S0028-3908(99)00159-8
   PubMed Web of Science ®Google Scholar
• Kufareva, I., & Abagyan, R. (2012). Methods of protein structure comparison. Methods Mol. Biol. Clifton NJ, 857, 231–257. 10.1007/978-1-61779-588-6_10
   PubMedGoogle Scholar
• Roy, K., Kar, S., & Narayan Das, R. (2015). A primer on QSAR/QSPR modeling (p. 121). Cham: Springer.
   Google Scholar
• Ladduwahetty, T., Gilligan, M., Humphries, A., Merchant, K. J., Fish, R., McAlister, G., Ivarsson, M., Dominguez, M., O’Connor, D., & MacLeod, A. M. (2010). Non-basic ligands for aminergic GPCRs: The discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders. Bioorganic and Medicinal Chemistry Letters., 20(12), 3708–3712. doi:10.1016/j.bmcl.2010.04.090
   PubMed Web of Science ®Google Scholar
• Lin, F., Li, F., Wang, C., Wang, J., Yang, Y., Yang, L., & Li, Y. (2017). Mechanism exploration of arylpiperazine derivatives targeting the 5-HT2A receptor by in silico methods. Molecules, 22(7), 1064. doi:10.3390/molecules22071064
   Web of Science ®Google Scholar
• Lin, S.-H., Lee, L.-T., & Yang, Y. K. (2014). Serotonin and mental disorders: A concise review on molecular neuroimaging evidence. Clinical Psychopharmacology and Neuroscience, 12(3), 196–202. doi:10.9758/cpn.2014.12.3.196
   PubMed Web of Science ®Google Scholar
• Lomize, M. A., Lomize, A. L., Pogozheva, I. D., & Mosberg, H. I. (2006). OPM: Orientations of proteins in membranes database. Bioinformatics , 22(5), 623–625. doi:10.1093/bioinformatics/btk023
   PubMed Web of Science ®Google Scholar
• Marek, G. J., Carpenter, L. L., McDougle, C. J., & Price, L. H. (2003). Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology, 28(2), 402–412. doi:10.1038/sj.npp.1300057
   PubMed Web of Science ®Google Scholar
• Marvin Sketch v 16.10.24, (2016). ChemAxon, Budapest, Hungary.
   Google Scholar
• Meltzer, H. Y. (2004). What’s atypical about atypical antipsychotic drugs?. Current Opinion in Pharmacology., 4(1), 53–57. doi:10.1016/j.coph.2003.09.010
   PubMed Web of Science ®Google Scholar
• Mitra, P., (2017). A QSAR model of Olanzapine derivatives as potential inhibitors for 5-HT2A Receptor. Bioinformation, 13(10), 339–342., Rastogi, A., Rajpoot, M., Kumar, A., & Srivastava, V. doi:10.6026/97320630013339
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Mukhtar, S., Sajid Kiani, Y., & Jabeen, I. (2017). Molecular docking simulations and GRID-independent molecular descriptor (GRIND) analysis to probe stereoselective interactions of CYP3A4 inhibitors. Medicinal Chemistry Research, 26(10), 2322–2335. doi:10.1007/s00044-017-1933-7
   Web of Science ®Google Scholar
• Munk, C., Isberg, V., Mordalski, S., Harpsøe, K., Rataj, K., Hauser, A. S., Kolb, P., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016). GPCRdb: The G protein-coupled receptor database – an introduction. British Journal of Pharmacology., 173(14), 2195–2207. doi:10.1111/bph.13509
   PubMed Web of Science ®Google Scholar
• Munusamy, V., Yap, B. K., Buckle, M. J. C., Doughty, S. W., & Chung, L. Y. (2013). Structure-based identification of aporphines with selective 5-HT(2A) receptor-binding activity. Chemical Biology & Drug Design, 81(2), 250–256. doi:10.1111/cbdd.12069
   PubMed Web of Science ®Google Scholar
• Ojha, P. K., & Roy, K. (2011). Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection. Chemometrics and Intelligent Laborary Systems., 109(2), 146–161. doi:10.1016/j.chemolab.2011.08.007
   Web of Science ®Google Scholar
• Ostrowska, K., Grzeszczuk, D., Głuch-Lutwin, M., Gryboś, A., Siwek, A., Leśniak, A., Sacharczuk, M., & Trzaskowski, B. (2018). 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives. Bioorganic and Medicinal Chemistry., 26(2), 527–535. doi:10.1016/j.bmc.2017.12.016
   PubMed Web of Science ®Google Scholar
• Pándy-Szekeres, G., Munk, C., Tsonkov, T. M., Mordalski, S., Harpsøe, K., Hauser, A. S., Bojarski, A. J., & Gloriam, D. E. (2018). GPCRdb in 2018: Adding GPCR structure models and ligands. Nucleic Acids Research, 46(D1), D440–D446. doi:10.1093/nar/gkx1109
   PubMed Web of Science ®Google Scholar
• Pastor, M., Cruciani, G., McLay, I., Pickett, S., & Clementi, S. (2000). GRid-INdependent Descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. Journal of Medicinal Chemistry, 43(17), 3233–3243. doi:10.1021/jm000941m
   PubMed Web of Science ®Google Scholar
• Pazos, A., Probst, A., & Palacios, J. M. (1987). Serotonin receptors in the human brain–IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience, 21(1), 123–139. doi:10.1016/0306-4522(87)90327-7
   PubMedGoogle Scholar
• Pearlman, R. S. (1993). 3D QSAR in Drug design: Theory methods and applications (1st ed.). Leiden, Holland: ESCOM Science Publishers.
   Google Scholar
• Pentacle, v 1.0.6, (2009). Molecular Discovery Ltd., Perugia, Italy.
   Google Scholar
• Perani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008). In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. NeuroImage, 42(1), 306–314. doi:10.1016/j.neuroimage.2008.04.233
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. doi:10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Raote, I., Bhattacharya, A., & Panicker, M. M. (2007). Serotonin 2A (5-HT2A) receptor function: ligand-dependent mechanisms and pathways. In A. Chattopadhyay, (Ed.), Serotonin Receptors in Neurobiology, Frontiers in Neuroscience. Boca Raton, FL: CRC Press/Taylor & Francis.
   Google Scholar
• Reva, B. A., Finkelstein, A. V., & Skolnick, J. (1998). What is the probability of a chance prediction of a protein structure with an rmsd of 6 å?. Folding and Design., 3(2), 141–147.(98)00019-4 doi:10.1016/S1359-0278(98)00019-4
   PubMedGoogle Scholar
• Roothaan, C. C. J. (1951). New developments in molecular orbital theory. Reviews of Modern Physics, 23(2), 69–89. doi:10.1103/RevModPhys.23.69
   Web of Science ®Google Scholar
• Roy, K., Kar, S., & Ambure, P. (2015). On a simple approach for determining applicability domain of QSAR models. Chemometrics and Intelligent Laborary Systems., 145, 22–29. doi:10.1016/j.chemolab.2015.04.013
   Web of Science ®Google Scholar
• Roy, K., Mitra, I., Kar, S., Ojha, P. K., Das, R. N., & Kabir, H. (2012). Comparative studies on some metrics for external validation of QSPR models. Journal of Chemical Information and Modeling, 52(2), 396–408. doi:10.1021/ci200520g
   PubMed Web of Science ®Google Scholar
• Roy, P. P., & Roy, K. (2008). On some aspects of variable selection for partial least squares regression models. QSAR & Combinatorial Science, 27(3), 302–313. doi:10.1002/qsar.200710043
   Google Scholar
• Ruzic, D., Petkovic, M., Agbaba, D., Ganesan, A., & Nikolic, K. (2019). Combined ligand and fragment-based drug design of selective histone deacetylase - 6 inhibitors. Molecular Informatics, 38,e1800083 (1-15). doi:10.1002/minf.201800083
   PubMed Web of Science ®Google Scholar
• Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395. doi:10.1124/pr.112.007336
   PubMed Web of Science ®Google Scholar
• Smith, C. (2003). Drug target validation: Hitting the target. Nature, 422(6929), 342–345. 341, 343, 345 passim. doi:10.1038/422341a
   PubMed Web of Science ®Google Scholar
• SPSS Inc. v 18.0, (2009). PASW Statistics for Windows, Chicago, IL.
   Google Scholar
• Stewart, J. J. P. (1989a). Optimization of parameters for semiempirical methods II. Applications. Journal of Computational Chemistry, 10(2), 221–264. doi:10.1002/jcc.540100209
   Web of Science ®Google Scholar
• Stewart, J. J. P. (1989b). Optimization of parameters for semiempirical methods I. Method. Journal of Computational Chemistry, 10(2), 209–220. doi:10.1002/jcc.540100208
   Web of Science ®Google Scholar
• Tan, E. J., & Rossell, S. L. (2014). Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery. Schizophrenia Research, 152(1), 242–245. doi:10.1016/j.schres.2013.11.001
   PubMed Web of Science ®Google Scholar
• Tropsha, A. (2010). Best practices for QSAR model development, validation, and exploitation. Molecular Informatics, 29(6-7), 476–488. doi:10.1002/minf.201000061
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry, 31, 455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31, 671–690. doi:10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., Shoichet, B. K., Dror, R. O., & Roth, B. L. (2017). Crystal Structure of an LSD-bound human serotonin receptor. Cell, 168(3), 377–389.e12. doi:10.1016/j.cell.2016.12.033
   PubMed Web of Science ®Google Scholar
• Walitza, S., Bové, D. S., Romanos, M., Renner, T., Held, L., Simons, M., Wewetzer, C., Fleischhaker, C., Remschmidt, H., Warnke, A., & Grünblatt, E. (2012). Pilot study on HTR2A promoter polymorphism, -1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder. Journal of Neural Transmission, 119(4), 507–515. Vienna Austria 1996. doi:10.1007/s00702-011-0699-1
   PubMed Web of Science ®Google Scholar
• Wang Gallaher, S. (1993). Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: Identification of amino acids necessary for ligand binding and receptor activation. Molecular Pharmacology, 43(6), 931–940.
   PubMed Web of Science ®Google Scholar
• Wermuth (2003)., The practice of medicinal chemistry (2nd ed.). San Diego, CA: Academic Press.
   Google Scholar
• Wilson, K. J., van Niel, M. B., Cooper, L., Bloomfield, D., O’Connor, D., Fish, L. R., & MacLeod, A. M. (2007). 2,5-Disubstituted pyridines: The discovery of a novel series of 5-HT2A ligands. Bioorganic and Medicinal Chemistry Letters., 17(9), 2643–2648. doi:10.1016/j.bmcl.2007.01.098
   PubMed Web of Science ®Google Scholar
• Wold, S., Eriksson, L., Trygg, J., & Kettaneh, N. 2004. The PLS method – partial least squares projections to latent structures – and its applications in industrial RDP (research, development, and production). 45.
   Google Scholar
• Yu, W., He, X., Vanommeslaeghe, K., & MacKerell, A. D. (2012). Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations. Journal of Computational Chemistry, 33(31), 2451–2468. doi:10.1002/jcc.23067
   PubMed Web of Science ®Google Scholar
• Yuan, X., & Xu, Y. (2018). Recent Trends and Applications of Molecular Modeling in GPCR−Ligand Recognition and Structure-Based Drug Design. International Journal of Molecular Sciences, 19,1-16. doi:10.3390/ijms19072105
   Web of Science ®Google Scholar
• Zhang, C., Li, Q., Meng, L., & Ren, Y. (2019). Design of novel dopamine D 2 and serotonin 5-HT 2A receptors dual antagonists toward schizophrenia: An integrated study with QSAR, molecular docking, virtual screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 38(3), 860-885. https://doi.org/doi:10.1080/07391102.2019.1590244
   Google Scholar